JNJ Related Insiders' Blog
-
Johnson & Johnson (JNJ) Unloads Entire Elan (ELN) Stake; Says Not Tied to Royalty Pharma Bid
-
California Jury Says J&J (JNJ) Defectively Designed ASR Hip Device
-
Warburg Said to Pick JPMorgan to Lead Massive Bausch & Lomb IPO
-
Meet Your 2013 Dogs of the Dow
-
Leggett & Platt (LEG), Dividends Aristocrats and the Fiscal Cliff
-
StreetInsider.com's Stocks for an Obama Victory
-
StreetInsider.com Guide for Presidential Election Stocks
-
Vertex (VRTX) Pops Higher, Enters Two New HCV Treatment Collaborations
-
Alzheimer's Treatment Pharmas on Watch as Merz Gets Positive CHMP Opinion for Memantine MAA
-
Johnson & Johnson (JNJ) Said to Settle Risperdal Case on First Day; Shares Move Higher
-
Medivation (MDVN) Ripe for the Picking on Expected Enzalutamide Approval
-
J&J (JNJ) Has Solid Defense as Offense Begins Falling into Place - Barron's
-
Former Stryker (SYK) CEO Sends Strong Message to Other Execs: Ask First
-
Employee Advocacy Group Demands Separation of Chair, CEO Roles at 9 Large Publicly-Traded Companies
-
Perrigo (PRGO) Not Generic When It Comes to Growth Potential - Cramer
-
Stocks See Relief
-
Find Saftey in These Top Dividend Aristocrats in This Crappy Market
-
Use the Sell-Off To Buy Warren Buffett's Accidental High-Yielders
-
Gilead (GILD) Could Be Set for More Gain than Pain - Barron's
-
Corporate Earnings for Q1 Look Promising So Far, Here's the Top Movers...
-
What's $70M Worth to Johnson & Johnson (JNJ)? Not as Much as You Think
-
Q4 Preview: Johnson & Johnson (JNJ) Looks for Cure to the Recall Blues
-
Radient Pharmaceuticals (RPC) Down 8% After Response to J&J Cancer Test
-
Michael Farr: Top-Stock Picks for 2011 Include Exxon Mobil (XOM), Microsoft (MSFT), Cisco (CSCO)
-
Bank of America (BAC), Johnson & Johnson (JNJ) Among Strategist's Large Cap 2011 Top Picks (INTC, XOM, T)
-
Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
-
Alcoa Kicks Off Q3 with Earnings on October 7, Big Names to Follow (AAPL, F, JNJ, GOOG, C, More...)
-
Paulson Sees $4,000 Gold and Says "Buy a Home"
-
Rumor Mill Sends Savient Pharma (SVNT) Shares Soaring
-
Wall Street Hubbub 9/17: Meet Lisa Falcone, Radware Talks Heat Up Again, First Marblehead Gets Up
-
Tepper's Appaloosa Increases Exposure to Big Pharma, Reduces Risk in Financials (C, BAC, MRK, PFE, More...)
-
Buffett's Berkshire Nearly Doubles Stake in J&J (JNJ), Shows New Stake In Fiserv (FISV)
-
Alcoa (AA) Kicks Off Q2 Earnings Season, Big Names to Follow (AAPL, GE, JPM, C, More...)
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Tepper's Appaloosa Cuts Stakes In Bank Stocks (BAC, C, WFC), Enters Pharmaceutical and Energy Stocks
-
Buffett's Berkshire Adds to Shares of IRM, RSG and BDX, Sells JNJ, KFT, PG, and Others
-
S&P Stocks With High Levels of European Exposure (PM, GILD, MCD...)
-
Boson Scientific (BSX) Earnings Preview: Shares Fibrillated Through Q1, Look to Restore Rhythm (STJ, MDT, JNJ)
-
Has the Market Already Downgraded U.S. Triple-A Rating?
-
Buffett's Berkshire Hathaway Ups Stakes In RSG and WFC, Lowers Stakes In PG and JNJ, Among Others Moves
-
China's Massive Investment Fund Discloses $9.63 Billion U.S. Portfolio (TCK, MS, BLK, V, more...)
-
Q3 Earnings Season Is Upon Us: GE, GOOG, JNJ, JPM, C, GS, BAC, INTC, CSX This Week
-
Buffett Shows New Stake In Beckton Dickson (BDX), Up Stake in J&J (JNJ)
-
Warren Buffett raises his stake in Johnson & Johnson (JNJ) by about 4.4 million shares
-
Short Interest Falls In C, GE, WFC, CAT, WMT, IBM, T, DIS, MCD, JNJ; Rises In BAC, F, CIT, JPM, AIG
-
Report J&J's Deal With Elan Could Turn Its Attention Toward Biogen (BIIB)
-
Johnson & Johnson (JNJ) Volatile as Q2 Results Lower, But Better Than Street Estimates
-
Aloca (AA) Set to Kick-Off Q2 Earnings Season... What Kind of Tone Will Be Set?
-
Article Speculates AMAG Pharmaceuticals (AMAG) Could Be A Takeover Target
-
Dividend Increases At Record Low, Dividend Cuts Highest In Over 50 Years
Back to JNJ Stock Lookup
